Literature DB >> 6330854

Late postpoliomyelitis muscular atrophy: clinical, virologic, and immunologic studies.

M C Dalakas, J L Sever, D L Madden, N M Papadopoulos, I C Shekarchi, P Albrecht, A Krezlewicz.   

Abstract

Seventeen relatively young patients, ages 31-65 years (average, 45) with prior poliomyelitis, who after a number of years of stability had experienced new neuromuscular symptoms, were studied. Seven patients had deterioration of functional capacity and then stabilization without new muscular weakness. The other 10 had late postpoliomyelitis muscular atrophy (late PPMA ) characterized by focal progressive muscle weakness, wasting, fasciculations, and muscle pains affecting previously spared muscles or muscles previously affected but recovered. Four patients with late PPMA had lymphorrhages or lymphocytic infiltrates in their biopsied muscle; three of three patients had oligoclonal IgG bands in their spinal fluid, and five had variable peripheral T lymphocyte-subset ratios. In one patient with late PPMA , antibodies to poliovirus were specifically elevated in the cerebrospinal fluid. Our findings indicate that new motor-neuron disease can occur in patients with prior poliomyelitis and that immunopathologic mechanisms may play a role.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330854     DOI: 10.1093/clinids/6.supplement_2.s562

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  10 in total

1.  Prior poliomyelitis-reduced capillary supply and metabolic enzyme content in hypertrophic slow-twitch (type I) muscle fibres.

Authors:  K Borg; J Henriksson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

Review 2.  Nucleic acid detection systems for enteroviruses.

Authors:  H A Rotbart
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

3.  Health and social status of elderly Asians: a community survey.

Authors:  L J Donaldson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

4.  Poliomyelitis in North America: the disease is not dead yet.

Authors:  T Johnstone
Journal:  CMAJ       Date:  1988-04-01       Impact factor: 8.262

5.  Persistent poliovirus infection in mouse motoneurons.

Authors:  J Destombes; T Couderc; D Thiesson; S Girard; S G Wilt; B Blondel
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome.

Authors:  I Leparc-Goffart; J Julien; F Fuchs; I Janatova; M Aymard; H Kopecka
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

7.  Macro EMG follow-up study in post-poliomyelitis patients.

Authors:  B Ivanyi; B W Ongerboer de Visser; P J Nelemans; M de Visser
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

8.  Circulatory autonomic failure 50 years after acute poliomyelitis.

Authors:  A D ten Harkel; J J van Lieshout; W Wieling
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

9.  Comparative study of spinal cord ubiquitin expression in post-poliomyelitis and sporadic amyotrophic lateral sclerosis.

Authors:  H Ito; A Hirano
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Dysphagia in postpolio patients: a videofluorographic follow-up study.

Authors:  B Ivanyi; S S Phoa; M de Visser
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.